Pharmaceutical companies launching across multiple indications, markets, or formulations are facing growing pressure to define pricing, contracting, and market access strategies earlier in the product lifecycle. These decisions are often made with limited visibility into downstream revenue, compliance, and execution impacts.

To help address this challenge, Model N has partnered with CCX to extend launch planning and market access strategy into pricing, contracting, and revenue execution workflows.

In this joint webinar, Model N and CCX provide a first look at how life sciences organizations can better connect global launch planning with commercial execution. You’ll learn why this partnership matters for teams preparing for launch, expansion, or loss of exclusivity, and how earlier, data‑driven decisions can reduce risk and improve outcomes across regions.

You’ll learn how to:

• Make earlier, higher‑confidence launch and market access decisions amid increasing global pricing complexity
• Use scenario planning to evaluate pricing and contracting options and understand downstream revenue and compliance impacts
• Align global, regional, and affiliate teams around shared, data‑driven launch assumptions
• Connect launch planning and market access strategy directly to pricing, tender, and revenue execution workflows
• Translate planning scenarios into executable, compliant commercial outcomes using CCX and Model N together

The session includes a live demonstration of CCX’s planning technology, showing how scenario modeling helps teams evaluate pricing and contract options, assess reference pricing and LOE impacts, and align global, regional, and affiliate stakeholders around clear decisions. You’ll also see how these scenarios connect directly into Model N’s pricing, tender, and revenue management workflows, helping ensure launch strategies translate into executable and compliant commercial outcomes.

Nathan Sigworth

Founder and Chief Executive Officer

CCX

Bernard Guiterrez

VP Solutions

Model N